Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis | Zendy

Edward Broughton | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis

Author(s) -

Edward Broughton

Publication year - 2007

Publication title -

journal of public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.916

H-Index - 82

eISSN - 1741-3850

pISSN - 1741-3842

DOI - 10.1093/pubmed/fdm055

Subject(s) - hib vaccine , medicine , vaccination , environmental health , cost effectiveness analysis , public health , cost effectiveness , developing country , disability adjusted life year , pediatrics , disease burden , demography , immunology , population , immunization , economic growth , risk analysis (engineering) , nursing , antigen , economics , conjugate vaccine , sociology

Haemophilus influenzae type B (Hib) causes significant morbidity and mortality in children under five years of age. A safe and effective vaccine is available but is not in general use in developing countries. This paper evaluates the cost-effectiveness of introducing Hib vaccine in Indonesia as an addition to the country's current DTP-Hepatitis B vaccination program.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research